MRI

In comparison to LI-RADS version 2018 for MRI assessment, the use of perfluorobutane-enhanced ultrasound incorporating Kupffer-phase findings yielded comparable sensitivity and specificity for detecting hepatocellular carcinoma (HCC) nodules < 20 mm in high-risk patients, according to new research.

Catch up on the top radiology content of the past week.

Catch up on the most-well viewed radiology content in February 2026.

Catch up on the most well-viewed video interviews from Diagnostic Imaging in February 2026.

Catch up on the top AI-related news and research in radiology over the past month.

In a recent interview, Jeremy Heit, M.D., Ph.D., discussed key neuroimaging takeaways from changes to the updated guideline from the American Heart Association and the American Stroke Association for early evaluation and management of patients with acute ischemic stroke.

Catch up on a variety of new FDA clearances and approvals in radiology from the past week.

Catch up on the top radiology content of the past week.

Previously approved by the FDA in 2022, the macrocyclic gadolinium-based MRI contrast agent gadopiclenol can now be utilized to detect lesions with abnormal vascularity in the central nervous system and other parts of the body for children under the age of two.

New MRI research suggests that adjunctive AI may lead to a significant reduction of unnecessary prostate biopsies.

The FDA clearances include the 1.5T SIGNA Sprint with Freelium MRI platform, the 3T SIGNA Bolt MRI system and the AI-powered SIGNA One, which reportedly enhances MRI workflow efficiencies.

In a recent interview, Yulin Ge, M.D., discussed emerging research showing correlations between brain MRI findings in patients with Long Covid and established blood biomarkers for Alzheimer’s disease.

The Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System reportedly enables larger tissue samples and facilitates more efficiency in procedure setup and cleanup with 75 percent less tubing in comparison to other systems.

A machine learning model incorporating cardiac MRI and clinical data provided a 91 percent AUC for predicting major adverse cardiovascular events (MACE) in patients with STEMI, according to a new study involving over 1,000 patients and a median follow-up of 40 months.

Sharing his perspective as well as insights from recently published research, Benjamin Kann, M.D., discussed the utility of AI foundation models for accessing an array of diagnostic and prognostic data from brain MRI scans.

Catch up on the top radiology content of the past week.

In a recent interview, Benjamin Kann, M.D., discussed new research highlighting the capability of an AI foundation model to obtain a variety of diagnostic and prognostic data from brain MRI scans.

Researchers found that PSMA PET/CT offered 18 percent higher accuracy than mpMRI in detecting bilateral intraprostatic disease, according to a new study involving patients with intermediate or high-risk prostate cancer.

Catch up on the top radiology content of the past week.

Catch up on a variety of new FDA clearances in radiology from the past week.

In a recent interview from the International Stroke Conference, Jeremy Heit, M.D., Ph.D., discussed new research suggesting that AI may offer better assessment than neuroradiologists of aneurysm growth on computed tomography or magnetic resonance angiography scans.

The Ascent3T Neonatal Magnetic Resonance Imaging System is reportedly the first high-field 3T system geared to neonatal applications.

Catch up on the top radiology content of the past week.

The Biograph One PET/MRI system may facilitate accelerated scan times, improved visualization and more efficient assessments of theranostic approaches for patients with oncologic and neurological diseases.

Catch up on the most-well viewed radiology content in January 2026.